Blast From the Past: “Pay for Delay” and the Blockbuster Patent Settlement
This article was originally published in RPM Report
Executive Summary
The Supreme Court wades into the competitive impact of so-called pay-for-delay settlements, while AstraZeneca and Actavis agree on the end of Crestor’s exclusivity period. Those developments are important – but not nearly as much as they used to be.